Compounded GLP-1
Check whether compounded GLP-1 can be routed, what restrictions may apply, and what to ask your prescriber or pharmacist.
About GLP-1
GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide — are injectable medications originally developed for type 2 diabetes and now widely used for weight management. Compounded versions are only available under specific FDA-permitted circumstances, such as a documented clinical reason the commercial product (Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda) is not suitable for the patient. Following the FDA's 2024 resolution of the tirzepatide and semaglutide shortages, compounded GLP-1s are no longer routinely available for supply or cost reasons.
Current legal status of compounded GLP-1s (2026)
As of 2026, compounded semaglutide and tirzepatide are not legal to dispense under the shortage-based exceptions that were in effect in 2022–2024. The FDA declared both shortages resolved in late 2024, which removes the basis for 503A pharmacies to compound widely distributed copies of the commercial products.
Compounding is still permitted on a case-by-case basis under Section 503A — for example, when a specific patient has a documented allergy to an inactive ingredient in the commercial product, or needs a non-commercial strength for a documented clinical reason. Cost alone is not a valid basis for compounding. Liraglutide remains compoundable under the same case-by-case rules.
Which GLP-1s can be compounded and when
Compounding pharmacies currently prepare GLP-1 receptor agonists only for patients whose prescribers document a specific clinical reason the commercial product is not appropriate.
Documented reasons can include: allergies to polysorbate, benzyl alcohol, phenol, or other excipients in the branded product; the need for a non-commercial strength to support a titration or tapering protocol that the commercial product cannot match; or other medically documented circumstances. A pharmacy offering widely distributed compounded semaglutide or tirzepatide without that documentation is operating outside FDA guidance and should be a red flag.
Commercial GLP-1 products — and when they're the right answer
For most patients, the commercial branded products are the correct choice: Ozempic and Wegovy (semaglutide), Mounjaro and Zepbound (tirzepatide), Saxenda (liraglutide), and Rybelsus (oral semaglutide).
All are covered by most commercial insurance plans for appropriate indications, and both Novo Nordisk and Eli Lilly operate patient savings programs that can reduce out-of-pocket costs significantly. Eli Lilly's LillyDirect and Novo Nordisk's NovoCare also offer direct-pay options at lower monthly costs. If your prescriber does not have a documented clinical reason to compound, the commercial product plus manufacturer savings is the appropriate path.
Key Questions About GLP-1
Can I get GLP-1 compounded?
Not through Compounding Finder right now. A prescriber and pharmacist still have to decide whether any compounded GLP-1 preparation is legally and clinically appropriate.
Will Compounding Finder send my GLP-1 request to pharmacies?
No. Compounding Finder is not sending GLP-1 quote requests to pharmacies at this time, so we cannot return GLP-1 quotes or prices. If FDA guidance changes, we will revisit.
Source notes: FDA explains that compounded drugs are not FDA-approved finished products and describes 503A compounding around patient-specific prescriptions. See Compounding and the FDA and Section 503A.
Frequently Asked Questions
Is compounded semaglutide still legal in 2026?
Compounded semaglutide is legal only on a case-by-case basis under Section 503A — for example, when a prescriber documents that the patient has an allergy to an inactive ingredient in Ozempic or Wegovy, or needs a non-commercial strength for a documented clinical reason. The shortage-based exception that allowed widely distributed compounding in 2022–2023 ended when the FDA declared the semaglutide shortage resolved in late 2024. Cost alone is not a valid basis for compounding.
Can I get compounded tirzepatide instead of Zepbound for cost savings?
No. Under FDA rules, cost is not a valid clinical reason to compound a drug that is commercially available. A prescriber must document a specific clinical reason — an allergy to an inactive ingredient, a need for a non-commercial strength, or another medically documented circumstance — for a compounded version to be appropriate. Eli Lilly's direct-pay program (LillyDirect) offers Zepbound at reduced out-of-pocket cost and is the appropriate path for most cost-sensitive patients.
What's the difference between compounded semaglutide and Ozempic or Wegovy?
Ozempic and Wegovy are FDA-approved branded semaglutide products manufactured by Novo Nordisk under strict quality controls. Compounded semaglutide is prepared by a licensed pharmacist under state pharmacy compounding standards and is not FDA-evaluated for batch safety or efficacy. The active ingredient can be the same, but compounded versions may differ in excipients, concentration, storage requirements, and potency tolerance. Compounded versions should only be used when commercial branded products are clinically inappropriate for a specific patient.
How do I know a GLP-1 pharmacy is legitimate?
Verify the pharmacy is licensed in your state through your state board of pharmacy, confirm they hold a compounding permit, and ask whether they are inspected by PCAB (Pharmacy Compounding Accreditation Board) or registered as a 503B outsourcing facility. Avoid any seller that ships GLP-1s without a prescription, non-U.S. online pharmacies, or any vendor marketing peptides as "research chemicals." Compounding Finder only works with licensed U.S. compounding pharmacies.
We Do Not Currently Route GLP-1 Quote Requests
Semaglutide and tirzepatide were removed from the FDA drug shortage list, so a compounding pharmacy can only prepare them when there is a specific, documented medical reason the brand will not work. If FDA guidance changes, we will revisit.
What actually works instead
The compliant path is the manufacturer's own pharmacy. Ask your prescriber to send the prescription there, or check your insurance coverage.
- Wegovy through NovoCare Pharmacy
Ask your prescriber to send your Wegovy prescription electronically to “NovoCare Pharmacy.” NovoCare Pharmacy handles payment and ships to your home directly.
Get Wegovy at NovoCare Pharmacy → - Ozempic through NovoCare Pharmacy
Ask your prescriber to send your Ozempic prescription electronically to “NovoCare Pharmacy.” NovoCare Pharmacy handles payment and ships to your home directly.
Get Ozempic at NovoCare Pharmacy → - Zepbound through LillyDirect
Ask your prescriber to send your Zepbound prescription electronically to “LillyDirect Self Pay Pharmacy Solutions.” LillyDirect handles payment and ships to your home directly.
Get Zepbound at LillyDirect → - Compounded semaglutide and tirzepatide: what changed
What the rules actually say, why pharmacies stopped, and the legitimate lower-cost paths that still exist.
See your real options for semaglutide & tirzepatide →
Links to external price-comparison tools and retail pharmacies are provided for convenience. Compounding Finder is not affiliated with these services and does not receive information about your purchases. Always consult your prescriber before changing medications.